GLP-1 receptor (GLP-1R) signaling contributes to increased glucose-dependent insulin secretion, cell proliferation, islet size, portal glucose sensing, and postprandial lipid metabolism [3]
However, the oral segment will expand rapidly, due to the launch of novel medications like Rybelsus (oral semaglutide) and the widespread trend towards proactive health management
Zhao Q, Xu H, Zhang L, Liu L, Wang L
Undiagnosed masses or suspicious findings on imaging or examination should prompt delay of BPC-157 use until proper evaluation is complete
The best choice depends on your individual health condition and treatment goals
Tirzepatide is a dual-agonist that targets the GIP and GLP-1 receptors, while retatrutide is a tri-agonist, targeting the GIP, GLP-1, and glucagon receptors for a broader effect on metabolism and energy expenditure